| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
Department of Biology, The Johns Hopkins University, 3400 N. Charles Street, Baltimore, Maryland 21218
Received 24 November 2006/ Accepted 21 March 2007
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
To better understand the activity and regulation of relaxosomes, we have been examining transfer of F factor or F plasmid. For F plasmid, a much-studied model of conjugative transfer, the relaxosome includes plasmid-encoded TraY and TraI as well as host-encoded integration host factor (IHF) (17). TraY and IHF are double-stranded DNA-binding accessory proteins that bend DNA (25, 31, 32), possibly creating a single-stranded DNA (ssDNA) conformation suitable for TraI binding. TraI, a sequence-specific ssDNA nuclease or relaxase, cleaves a single plasmid strand, which is subsequently transferred to the recipient. In the recipient, the complementary strand is synthesized and the plasmid is circularized (10, 20, 41).
The F relaxosome forms within a region of F oriT (Fig. 1). The F oriT is complex, containing several protein-binding sites (sbi, ihfA, ihfB, sbyA, and sbmC-sbmA) and structural elements (intrinsic bends, direct repeats [DR], inverted repeats [IR], and A-tracts). As shown in Fig. 1, the position of TraI cleavage, nic, is located on the bottom DNA strand, and all protein-binding sites and the majority of the structural elements are located 5' to nic (to the right as depicted) (7, 12, 19, 26, 38, 39). Sites ihfA and sbyA are positioned closest to nic, and these three protein-binding sites (sbi, ihfA, and sbyA) along with their associated proteins are implicated in the nicking reaction (13, 27). Three TraM-binding sites (sbmC, sbmB, and sbmA) and the lower-affinity IHF site, ihfB, are located beyond sbyA (to the right as shown in Fig. 1). The sbmC site, which is bound with lowest affinity and partially overlaps sbyA (7, 12), is not necessary for nicking but is required for transfer (13). Sites sbmB and sbmA are involved in the regulation of TraM expression (11, 30, 37). Site ihfB is positioned between sbmC and sbmB (12, 39) and is not implicated in nicking (13, 27).
|
Our earlier footprinting results suggested that the sbyA site consists of three subsites each bound by a TraY monomer (22). Two subsites are arranged as an imperfect IR (Fig. 1) that contains the GA(T/G)A high-affinity subsites to which TraY binds cooperatively. The third subsite, which appears to be arranged as a DR with its adjacent site, is either bound at higher TraY concentrations or bound cooperatively with the TraY molecules at the IR, depending on the DNA construct and experimental method used (22). Our previous work demonstrated that substitutions within the IR yielded the greatest reductions in in vitro binding (22). The addition or subtraction of two base pairs between the sbyA subsites also altered binding affinity (22).
Here we describe our initial examination of the F relaxosome. In this series of experiments, we undertook to determine the importance of the TraY and IHF oriT binding sites and their spacing to plasmid transfer. First, using EMSA we measured TraY and IHF binding affinities for oligonucleotides with multiple substitutions in the high-affinity sbyA IR and throughout ihfA. We confirmed the location and sequence of the IHF-binding site, ihfA, and identified variant sbyA and ihfA sites bound with significantly reduced affinity. We then introduced the same substitutions into plasmids and assayed them for mobilization efficiency. We also inserted half and full helical turns between the relaxosome protein-binding sites and assayed for mobilization efficiency. We found that while base substitutions can significantly reduce in vitro binding, these substitutions have little effect on mobilization. In contrast, the insertions between TraI-, IHF-, and TraY-binding sites dramatically reduce mobilization efficiency.
| MATERIALS AND METHODS |
|---|
|
|
|---|
(lacZ)M15 zzf::Tn10(Tetr)/fhuA2 glnV
(lac-proAB) thi-1
(hsdS-mcrB)5], ER2267 [F' proA+B+ lacIq
(lacZ)M15 zzf::mini-Tn10 (Kanr)/
(argF-lacZ)U169 glnV44 e14(McrA) rfbD1? recA1 relA1? endA1 spoT1? thi-1
(mcrC-mrr)114::IS10], and TB1 {F ara
(lac-proAB) [
80dlac
(lacZ)M15] rpsL (Strr) thi hsdR}, and plasmids pNEB193 and pACYC177 were obtained from New England BioLabs. E. coli strain XL-1 Blue was purchased from Stratagene. Plasmids pACYC177-ForiT (42) and pNEB193-ForiT (36) were constructed as described elsewhere. The question marks included in the ER2267 genotype indicate genes that ER2267 should contain based on the ancestral strain but that have not been verified by direct testing of ER2267. Site-directed mutagenesis. Base substitutions in the F oriT region of pNEB193-ForiT and pACYC177-ForiT and insertions in the F oriT region of pACYC177-ForiT were introduced using a QuikChange kit (Stratagene). After confirming mutations using DNA sequencing, each plasmid variant was transformed into ER2267 and/or ER2738.
Plasmid mobilization assay. Mobilization assays were performed as described previously (42). Variants of pACYC177-ForiT were tested using F' strain ER2738 and the recA F' strain ER2267 as donors. Variants were also created in pNEB193-ForiT and tested using ER2738 as a donor strain. Overnight cultures of ER2738 with wild-type (WT) or variant pNEB193-ForiT (using pNEB193 as a negative control) or WT or variant pACYC177-ForiT (using pACYC177 as a negative control) were grown in Luria-Burtani (LB) broth containing tetracycline (25 µg/ml) and ampicillin (100 µg/ml) (LB+Tet+Amp). Overnight cultures of ER2267 with WT or variant pACYC177-ForiT constructs, using pACYC177 as a negative control, were grown in LB containing kanamycin (30 µg/ml) and ampicillin (100 µg/ml) (LB+Kan+Amp). To follow plasmid mobilization, serial dilutions of each assay were plated onto LB+Amp to select for donors and LB+Amp+Strep to select for transconjugates. To follow F' transfer, dilutions were plated onto LB+Tet (ER2738) or LB+Kan (ER2267) to select for donors and on LB+Tet+Strep (ER2738) or LB+Kan+Strep (ER2267) to select for transconjugates. Mobilization efficiencies were calculated as the number of transconjugates per donor. These measurements are presented as an average of 3 to 35 experiments with the standard errors.
Expression and purification of TraY. TraY was expressed as described previously (34) with minor modifications. Strain BL21(DE3)/pET-21a(+)-traY was grown in 0.5 liters of LB+Amp at 37°C to an optical density at 600 nm of 0.5. Protein expression was induced by adding isopropyl-1-thio-ß-D-galactopyranoside to a final concentration of 1 mM. Cells were grown for an additional 3 h at 37°C. Cells were centrifuged at 10,000 x g for 20 min, and pellets were frozen at 80°C. TraY was purified as described previously (23) with some changes. Cell pellets were thawed at 4°C and resuspended in 50 ml of ice-cold buffer A (50 mM Tris [pH 7.5], 1 mM EDTA, and 5 mM ß-mercaptoethanol [ß-ME]) with 100 mM NaCl. Phenylmethylsulfonyl flouride was added to a final concentration of 200 µM. Cells were lysed by sonication, and membranes were pelleted by centrifugation at 10,000 rpm for 10 min at 4°C. Supernatant was loaded onto a 5-ml HiTrap Q column (GE Healthcare) equilibrated with buffer A plus 100 mM NaCl. A gradient from 100 mM to 2 M NaCl was applied to the column at 5 ml/min over a 100-ml volume. Flowthrough was loaded on a 5-ml HiTrap heparin column (GE Healthcare) equilibrated with buffer B (20 mM NaPO4 [pH 7.4], 1 mM EDTA, and 5 mM ß-ME) with 100 mM NaCl. A salt gradient was run from 100 mM to 1 M NaCl. Protein eluting at 500 to 670 nM NaCl was loaded onto a 5-ml HiTrap Blue column (GE Healthcare) equilibrated with buffer B plus 500 mM NaCl, and a 500 mM to 3.8 M salt gradient was applied. Fractions eluting between 1.7 M and 2.8 M NaCl were combined and dialyzed overnight into buffer B with 100 mM NaCl. The dialysate from the Blue column was loaded onto a 5-ml HiTrap SP Sepharose column (GE Healthcare) equilibrated with buffer B plus 100 mM NaCl, and a gradient was run from 100 mM to 1 M NaCl. The single TraY peak that eluted from 450 mM to 630 mM NaCl was mixed 1:1 with 4 M NaCl and concentrated over a 1-ml butyl-Sepharose 4 Fast Flow column (GE Healthcare) equilibrated with buffer B plus 3.8 M NaCl. TraY fractions were pooled and dialyzed in buffer B with 100 mM NaCl. Dialysate was further concentrated with a centrifugal filter device (Millipore). The protein concentration was calculated from the A280 using the extinction coefficient of 11,460 M1 cm1. Purity of TraY was determined to be >95% as seen by Coomassie-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Expression and purification of IHF. IHF was expressed and purified as previously described (9) with minor modifications. HN880 pPLhip.himA-5 cells were grown in LB with 50 µg/ml ampicillin at 30°C to an optical density at 600 nm of 0.5. Overexpression was induced by shifting the culture temperature to 42°C for 3 h. Cells were pelleted by centrifugation at 3,700 rpm for 30 min at 4°C, and the pellet was frozen at 80°C. The pellet was resuspended in buffer C (25 mM Tris-HCl pH 7.4, 1 mM EDTA, 20 mM NaCl, 3 mM ß-ME) at 0.2 ml/g pellet and 5 mM MgCl2 and 1 mM phenylmethylsulfonyl fluoride (final concentrations). Cells were lysed by sonication, incubated on ice for 30 min, and then pelleted by centrifugation at 43,000 x g for 35 min. A two-step ammonium sulfate precipitation was performed. First, 0.33 g ammonium sulfate/ml supernatant was added to the supernatant followed by centrifugation at 43,000 x g for 20 min at 4°C. Second, 0.56 g ammonium sulfate/ml supernatant was added to the supernatant from the first step followed by another centrifugation step. The pellet was resuspended in buffer C (30 ml/500 ml of original culture) and dialyzed against 4 liters of buffer C. The dialysate was filtered through a 0.45-µm filter and was applied to a 5-ml HiTrap heparin column equilibrated with buffer C. A salt gradient was run from 20 mM to 2 M NaCl. IHF fractions were pooled and dialyzed in buffer C with 20 mM NaCl. Dialysate was further concentrated with a centrifugal filter device (Millipore). The protein concentration was calculated from the A280 using the extinction coefficient 5,960 M1 cm1. Purity of IHF was determined to be >95% as seen by Coomassie-stained sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
Labeling oligonucleotides.
Single stranded WT and mutant sbyA or ihfA oligonucleotides were 5' end-labeled with [
-32P]ATP (GE Healthcare) using T4 polynucleotide kinase (New England BioLabs) according to the manufacturer's instructions. The complementary strand was then mixed 3:1 with the labeled strand, heated to 95°C for 5 min, and slow cooled for 3 h. Unincorporated nucleotides were separated from labeled oligonucleotide using the Sephadex G-50 Fine quick spin columns (Roche).
Electrophoretic mobility shift assays.
EMSAs were performed as described elsewhere (23) with minor modifications. In EMSA buffer, ß-ME replaced dithiothreitol and 10 µg/ml replaced 1 µg/ml sonicated calf thymus DNA. Reaction mixtures were incubated for 60 instead of 90 min. The concentration range of
-32P-end-labeled WT or mutant sbyA oligonucleotide was 42.5 to 755 pM. The same procedure was followed using WT IHF protein and 51.0 to 95.7 pM of WT or mutant ihfA DNA sequence.
Data analysis.
Intensities of radioactive bands for each EMSA were determined using ImageQuant software v.1.2 (Molecular Dynamics) and were used without background correction. At each protein concentration, the fraction bound (
) was calculated for each bound species. We refer to these values as a partial fraction bound,
x. For example, the EMSA of WT TraY binding to the WT 39-bp sbyA oligonucleotide results in two predominate bound species (see Fig. 2, left upper panel, below). Therefore, a partial fraction bound was calculated for bound species 1,
1, and bound species 2,
2. Our interpretation of the data for the 39-bp oligonucleotides (see Results, below) is that bound species 1 represents two molecules of TraY bound, occupying the sbyA IR subsites GA(T/G)A, and bound species 2 consists of three bound TraY molecules occupying both the sbyA IR and an additional, possibly nonspecific site 3' to the GATA site. This latter site is referred to as the alternative site. (The 39-bp oligonucleotides do not contain an intact TTTC subsite, and TraY therefore will not bind to the sbyA DR.) TraY binding to the 50-bp oligonucleotides also yields two bound species, but we interpret
1 as representing cooperative binding of three TraY proteins to both the IR and DR, while
2 represents binding to the IR, DR, and the alternative binding site. Binding of the 44-bp oligonucleotide results in three bound species:
1 represents two TraY molecules binding cooperatively to the IR,
2 represents occupation of the IR and either the alternative binding site or the DR, and
3 represents occupation of the IR, the alternative binding site, and the DR. From these studies we cannot distinguish between TraY occupation of the DR and the alternative binding site; therefore, we cannot assign either binding event to the second or third bound species. (The 44-bp oligonucleotide does not extend far beyond the end of the TTTC subsite, and this potentially incomplete DR may exclude some contacts essential for the highest-affinity binding.) For all oligonucleotides, each binding event was graphed separately. For example, when using 39-bp oligonucleotides the IR is occupied in both bound species; therefore,
1 and
2 are added to give the total IR fraction bound at each protein concentration. The third bound TraY molecule is present only in the second bound species and, therefore,
2 equals the total alternative binding site fraction bound. Curves reflecting IR binding were fit with a two-site cooperative binding model: fraction IR occupied = 1/{1+(KD/[TraY]2)}. Curves reflecting cooperative IR/DR binding (50-bp oligonucleotides) were fit with a three-site cooperative binding model: fraction IR occupied = 1/{1+(KD/[TraY]3)}. Curves depicting alternative site binding, or DR binding in the 44-bp oligonucleotides, were fit with a single-site independent binding model: fraction alternative site occupied or fraction DR occupied = 1/{1+(KD/[TraY])}.
|
tot = (
1 +
2 +
3). IHF curves were fit with a one-site independent binding model: fraction specific IHF site occupied = 1/{1+(KD/[IHF])}. To better compare binding affinities, all KD values were converted to half-maximal DNA binding concentrations (half-max, or [protein]1/2). The half-max is the protein concentration required to occupy half of a given binding site. For data fit with the single-site binding model, the KD equals the half-max. For data fit with the two-site cooperative model, the square root of the KD value equals the half-max, and for data fit with the three-site cooperative model, the cube root of the KD value equals the half-max. A ratio of the average half-max for each variant construct compared to the average half-max of its corresponding WT construct was calculated and reported as the relative half-max (relative [protein]1/2).
| RESULTS |
|---|
|
|
|---|
The binding affinities of TraY for the WT and variant sbyA sites were determined using EMSA. In Fig. 2, the upper left panel shows a representative EMSA for TraY binding to the WT 39-bp sbyA oligonucleotide. The fastest migrating bands represent free oligonucleotide. As TraY concentration increases, the oligonucleotide becomes bound, ultimately resulting in three slower migrating species. Of these three bound species, one is marginally populated and likely represents one molecule of TraY binding, while the other two are the predominate bound species. We interpret the faster migrating of these two bound species (first bound species) as representing two cooperatively bound TraY molecules at the IR. The slower migrating band (second bound species), which appears at higher TraY concentrations, represents an additional bound TraY molecule at a location we refer to as the "alternative binding site" (see below). At the two highest TraY concentrations, the intensity of the two bound species begins to diminish, replaced by smearing, indicating nonspecific binding of additional TraY molecules.
The upper right panel of Fig. 2 shows a representative EMSA of TraY binding to a variant 39-bp sbyA site. The variant sbyA IR is bound with lowered affinity, as reflected in the greater TraY concentrations that were required to populate the first bound species of the 39-bp sbyA site variant, relative to the WT sequence. The second bound species of the 39-bp sbyA variant, however, appears at a TraY concentration similar to the concentration at which the second species appears for the WT sbyA site, indicating its affinity was not altered. Additionally, the appearance of a single bound molecule of TraY is more pronounced in 39-bp sbyA variants, presumably resulting from reduced binding to the subsite(s).
The oligonucleotides used for the binding experiments were also employed to engineer the same substitutions into plasmids utilized in the in vivo mobilization assays. The lengths of oligonucleotides used in the EMSAs varied depending on the area of substitution. The TCTC subsite variants were incorporated into 50-bp oligonucleotides, the GATA subsite substitutions consisted of 39-bp oligonucleotides, and the 44-bp oligonucleotides included variants with substitutions in both regions of interest. The differences in the oligonucleotides may have effects on protein-binding affinity; therefore, the binding affinity of each variant oligonucleotide is compared to the binding affinity of the WT sequence of the same length and reported as the relative half-max, relative [TraY]1/2.
Curves depicting TraY binding to a WT or variant 50-bp sbyA site were divided into two binding events: occupation of the IR/DR subsites ([TraY]1/2 = 0.6 nM) and binding to a less specific alternative binding site ([TraY]1/2 = 47 nM) (see Fig. S1, lower panels, in the supplemental material). (The alternative binding site is located to the right of the sbyA sites in Table 1.) The 39-bp sbyA oligonucleotides do not contain the third sbyA subsite, TTTC, included in the DR. The two binding events observed for the 39-bp oligonucleotides are therefore occupation of the IR ([TraY]1/2 = 2 nM) and binding to the alternative site ([TraY]1/2 = 50 nM) (Fig. 2). Three binding events were observed with the 44-bp oligonucleotides (see Fig. S2 in the supplemental material). We interpret the first of these as binding to the IR ([TraY]1/2 = 1.6 nM). We cannot unambiguously identify the second ([TraY]1/2 = 18 nM) and third ([TraY]1/2 = 120 nM) binding events. One represents binding to the TTTC subsite of the DR with an affinity reduced relative to the 50-bp oligonucleotides due to the absence of some base pairs involved in recognition of this subsite (the oligonucleotide extends only 1 bp beyond the TTTC sequence). The other represents binding to the alternative site. Affinities for both of these binding events are within threefold of the alternative sites of the 39-bp and 50-bp sites. We therefore refer to these two bands as the second and third bound species of the 44-bp oligonucleotide. The binding curves representing association with the IR (44-bp and 39-bp oligonucleotides) or the IR/DR (50-bp oligonucleotides) were fit with a cooperative model, whereas the binding curves representing binding to the alternative binding site or the DR were fit with an independent site binding model. The difference between the concentration of TraY needed for binding to the IR or IR/DR site and for binding to the alternative binding site of WT sbyA is greater than 1 order of magnitude. For the variant sbyA sites, the IR transition was noticeably shifted to higher TraY concentrations while the alternative binding site transition was modestly altered, resulting in an overlap of the two.
|
7-fold of WT. When all three of the above substitutions were combined, the binding affinity showed an improvement relative to the double substitutions, displaying a moderate fourfold decrease from WT. This result may be due to the creation of an alternative imperfect IR within the sbyA site. The C217G/T218A/C219G variant combined with T220 generates a GAGT subsite that can combine with a TCTC subsite (bp 208 to 211), creating an alternative imperfect IR. This new subsite pair, GAG(T/A), shifts the cooperative binding sites within sbyA while maintaining the preferred 5-bp spacing between subsites. This analysis of the binding is supported by the appearance of a third shifted band ([TraY]1/2 = 9 nM) not seen in EMSA for other 50-bp oligonucleotides, indicating an altered binding pattern for the C217G/T218A/C219G variant. We list values in Table 1 for this variant assuming that the first shifted band represents binding to an IR and the third shifted band represents binding to the alternative binding site, although we are not certain of this interpretation. Substitutions within the GATA subsite (bp 225 to 228) also showed reduced binding with a 5- to 15-fold increase in relative [TraY]1/2 for the IR (Table 1). When the G225C substitution was combined with either A226T or T227C, the half-max binding concentration increased 15-fold, while the A226T/T227C variant displayed a 9-fold difference. The G225C/A226T/T227C substitutions show only a fivefold decrease in binding affinity compared to WT. It is possible that like the C217G/T218A/C219G variant, the G225C/A226T/T227C substitutions have created an alternative pair of high-affinity binding sites for TraY, although we have not identified one.
Each of the variants incorporating a single base pair substitution in each half of the imperfect IR (C217G/T227C, T218A/T227C, and C219G/T227C) yielded 23- to 26-fold reductions in binding affinity (Table 1). The combination of two 2-bp substitutions, C217G/T218A/A226T/T227C, resulted in a 31-fold decrease in binding compared to WT. In contrast, the relative [TraY]1/2 for the DR and alternative binding sites of all sbyA variants remained similar to WT, with a maximal fourfold change within the 44-bp sbyA variants.
In addition to investigating the binding of TraY to variant sbyA sites, binding of the F relaxosome accessory protein IHF was examined. The F oriT IHF site, ihfA, is positioned between the sbi and sbyA binding sites (bp 168 to 194) (12, 39). This region contains the sequence AAATAGAGTGTTA (bp 182 to 194), which resembles the IHF consensus sequence WWWCAANNNNTTR. To confirm this sequence as the IHF-binding site and to identify ihfA variants bound by IHF with reduced affinity, we generated ihfA variants with substitutions in this region and in an A/T-rich region 5' to this sequence. The upper panels of Fig. 3 show representative EMSAs of IHF binding to either WT ihfA (left panel) or a variant ihfA (right panel) oligonucleotide. Both show multiple bound species with presumably the first bound species representing specific binding to ihfA and the other slower migrating bound species illustrating nonspecific binding. Binding to the variant oligonucleotide requires a higher concentration of IHF to occupy the first bound species, while the concentrations at which the second and third bound species become occupied were unaltered. This indicates that the first bound species represents IHF binding to its conserved ihfA site, whereas the other bound species are binding nonspecifically.
|
|
|
Plasmids with oriT sequences containing combinations of sbyA and ihfA substitutions were also tested. The combination variants assayed in the ER2267 (recA deficient) cell line reduced mobilization to 28% and 69% of WT, similar to individual sbyA and ihfA substitutions (Fig. 4C). These same variants examined in the ER2738 (recA+) cell line reduced mobilization to 7% and 58%, respectively, of WT. The C217G/T218A/C219G/T181G/A182C/A183G/A184C substitution in ER2738 is statistically different from WT with 99% confidence. However, the mobilization efficiencies of each construct in the recA+ background are not statistically different from the mobilization efficiencies of the same constructs in the recA-deficient background.
Mobilization efficiencies of F oriT spacer variants. Although most substitutions we tested in F oriT sbyA and ihfA measurably reduced in vitro binding, only one showed a significant, albeit modest, decrease in transfer. These results suggest several possibilities: (i) the reductions in binding affinities were not great enough to prevent in vivo occupation of the binding sites, (ii) the specific sequences of the sbyA and ihfA binding sites may not be the only factors required for TraY and IHF binding, or (iii) binding to sbyA and ihfA is not essential for transfer. To further investigate the role of the F oriT relaxosome protein-binding sites in transfer, their spacing and orientation with respect to each other were examined. We reasoned that if TraY and IHF were required for transfer, altering the spacing and/or phasing of their sites might alter transfer efficiency. Insertions of 5 or 10 bp were made at four oriT sites: (i) one between the sbi and ihfA binding sites, (ii) two between the ihfA and sbyA binding sites (one interrupts an A-tract in this region at bp 198 and the other, at bp 204, does not), and (iii) one between the sbyA and ihfB binding sites.
Single 5-bp insertions between sbi and ihfA or ihfA and sbyA decreased mobilization efficiency to
1% of WT (Fig. 5). The 10-bp insertion between sbi and ihfA along with the 10-bp insertion between ihfA and sbyA positioned at bp 198 showed 0.5% of WT mobilization. These results indicate the importance of the distance between oriT protein-binding sites and their orientation with respect to one another. If the reduction in mobilization were solely the result of altering the phasing of a relaxosome protein-binding site with respect to its neighboring protein-binding sites, then the 10-bp insertions would have restored mobilization efficiency to WT levels. The 10-bp insert between ihfA and sbyA at bp 204 decreased mobilization to 19% of WT, which is a significant reduction but not nearly as great as the reduction shown by the 5-bp insertion at this site or the 10-bp insertion at bp 198. The 5-bp insertion between sbyA and ihfB reduced mobilization to 37% of WT, while the 10-bp insertion between sbyA and ihfB yielded a mobilization efficiency similar to WT. In general, as the distance between nic and the insertions increases, the negative effect on mobilization decreases. The length of the spacing between the sbyA and ihfB binding sites and their distance from nic may provide sufficient flexibility to this region of DNA and, therefore, 5 or 10 additional base pairs do not drastically change the DNA topography.
|
| DISCUSSION |
|---|
|
|
|---|
Based on our previous work (22) and the data presented here, we conclude that one molecule of TraY binds to each of three subsites in the F oriT sbyA binding site. Two of the three subsites, TCTC (bp 216 to 219) and GATA (bp 225 to 228), separated by a 5-bp spacer, form an imperfect IR to which two molecules of TraY bind cooperatively. A third TraY molecule binds cooperatively to a third sbyA subsite (possibly TTTC, bp 206 to 209) oriented as a DR with the TCTC subsite. An additional TraY molecule can bind to a sequence outside of the IR and DR. This result was unexpected, given that binding in this region was not observed in earlier footprinting studies (22). We have no evidence that this binding is functionally relevant.
The IHF binding data presented here are consistent with a single molecule of IHF binding specifically to ihfA. The reduced affinity of the ihfA variants tested supports our contention that the ihfA sequence AAATAGAGTGTTA (bp 182 to 194), which resembles the IHF consensus sequence, WWWCAANNNNTTR, is the region within ihfA specifically bound by IHF.
Our analysis of sbyA variants underscores the relatively limited sequence specificity of TraY recognition for sbyA. Even combinations of base substitutions have relatively small effects on in vitro binding by TraY. We also see evidence of the relative complexity of the sbyA site. For example, the C217G/T218A/C219G triple variant shows improved binding compared to the C217G/C219G and T218A/C219G double substitutions, probably due to the creation of an alternative IR binding sequence within sbyA. IHF, like TraY, exhibits a relatively low level of sequence specificity. Binding specificity of IHF relies upon "indirect readout" of a DNA conformation in addition to direct readout of bases (31). TraY may also rely upon indirect readout to bind to its site, helping explain why it can recognize its site even though it is located in the midst of similar sequences.
When sbyA and ihfA substitutions were incorporated into plasmids and the plasmids tested for mobilization efficiency, most showed no statistically significant difference in efficiency from plasmids containing the wild-type oriT. The single exception was the variant C217G/T218A/C219G/T181G/A182C/A183G/A184C, and this variant showed a significantly reduced transfer efficiency only when strain ER2738, but not ER2267, was used as a donor strain. This apparent lack of correlation between the binding and mobilization results may be due to a failure to reduce binding affinities sufficiently to eliminate occupation of the binding sites in vivo. sbyA is bound with a severalfold-higher affinity than sbyB (22, 28), a TraY-binding site near the traY promoter, yet both sites appear to play functional roles in vivo (1, 15, 35). IHF also plays multiple roles in the cell and has many binding sites in both the chromosome and plasmid DNA. Apparent dissociation constants of IHF for binding sites in
phage range from 2 to 128 nM (40, 44). Presumably, to prevent in vivo binding to variant sbyA and ihfA sites, the affinities for the variant sites would have to be well below the affinities for their naturally occurring sites. We are not convinced that the affinity for the engineered sites was sufficiently reduced.
Another possibility for the lack of effect of the substitutions on transfer is that IHF and TraY are not essential to transfer. This seems unlikely, because although our changes to the specific binding sites for sbyA and ihfA did not greatly affect plasmid mobilization, inserting spacers between the oriT protein-binding sites disrupts transfer. Insertions of a half or full helical turn positioned between sbi and ihfA or ihfA and sbyA were poorly tolerated, reducing mobilization efficiencies to 0.5 to 1% of WT. These results indicate that the spacing of the protein-binding sites and perhaps the phasing of the sites cannot be altered without adversely affecting transfer.
We are not certain why insertions between sbi and ihfA and between ihfA and sbyA cause reduced transfer efficiency, but there are a number of possibilities. First, if TraY and IHF bind cooperatively to their sites within the relaxosome, with cooperativity arising either from direct physical interaction between the proteins or from an induced DNA conformation, altering the distance between the ihfA and sbyA could reduce cooperativity. The reduced cooperativity would cause reduced binding of TraY and IHF, leading to reduced TraI activity and therefore reduced transfer. Second, if the effects of TraY and IHF are due to a DNA conformational change propagated to sbi, increasing the distance between bound TraY and/or IHF and sbi could blunt the effect on sbi conformation. Third, IHF and/or TraY may directly interact with TraI to stabilize TraI binding or to affect TraI cleavage activity. Altering the distance between binding sites or altering the phasing of the bound proteins relative to each other would prevent direct protein-protein interactions. Fourth, altered spacing might affect events following ssDNA cleavage by TraI. TraI from F and related plasmids possesses a helicase activity in addition to its relaxase activity, and both activities are required for efficient transfer. Work from the Zechner lab on R1 TraI demonstrates that the helicase activity requires a significant ssDNA region 5' to the duplex to load onto DNA and initiate DNA strand separation (5, 6). If loading the TraI helicase at the relaxosome is a necessary step in initiating DNA transfer, then DNA insertions in the region might prevent helicase loading and dramatically reduce transfer efficiency.
As the distance between the inserted sequences and nic increase, the effect of the insertions on mobilization decreases. Plasmids with 5- and 10-bp insertions between the sbyA and ihfB sites have mobilization efficiencies similar to those with a wild-type oriT. This is not surprising. Occupation of sbi, ihfA, and sbyA is required for the nicking reaction (13, 17) while, using deletion analysis, ihfB was found to have no effect on in vitro (27) or in vivo (13) nicking. This result apparently distinguishes F from R100, a plasmid closely related to F. In R100, IHF binding to ihfB was shown to be important for transfer in vivo (1) and was suggested to form a complex with the TraM molecule occupying sbmC to aid in DNA transfer (2). Assuming that the same IHF-TraM complex is formed in F, the requirements for the spacing and orientation of the sbmC and ihfB binding sites, relative to nic, are not as stringent as for R100.
In F oriT, 10-bp insertions at either bp 198 or bp 204 are positioned between the ihfA and sbyA sites, yet there is a 36-fold difference in their mobilization efficiencies. The 5-bp inserts at these positions have a mobilization efficiency of
1% of WT, similar to the 10-bp insert at position 198. The 10-bp sequences we inserted at 198 and 204 are similar in sequence and G/C content, but the 10-bp insertion at position 198 interrupts an A-tract. The source of the differences in the mobilization efficiencies of plasmids containing these insertions is not clear. The insertions at different sites could have different effects on the transmission of a conformational change to nic. Alternatively, there may be an additional factor involved in the initiation of transfer. The possibility of direct protein-protein interactions between TraI and TraY has been previously proposed (18, 24, 27). Conceivably, the 10-bp insertions between ihfA and sbyA could decrease DNA flexibility of the surrounding region, making it difficult to closely position sbi and sbyA in order to promote protein-protein interactions. The flexibility of the DNA region between ihfA and sbyA may be affected differently by the two 10-bp insertions, explaining the variations in their mobilization efficiencies. Further experimentation to directly test for F relaxosome protein interactions will be necessary.
Insertions between F oriT relaxosome protein-binding sites reduce mobilization, even though substitutions within the specific binding sites are tolerated. Both the distance between binding sites and their orientation with respect to one another must be maintained for optimal mobilization. These results support a model including both indirect and possibly direct interactions between relaxosome proteins during the initiation of transfer. The changes in DNA topology at sbi caused by TraY and IHF bending do not fully explain the mechanism required for the recruitment of TraI to sbi. However, the conformational changes of F oriT DNA during the initiation of transfer also position TraY closer to sbi, highlighting the possibility of direct TraY-TraI interactions to encourage TraI binding (27).
| ACKNOWLEDGMENTS |
|---|
This work was supported by National Institutes of Health grant GM61017.
| FOOTNOTES |
|---|
Published ahead of print on 9 March 2007. ![]()
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
| REFERENCES |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||